GW Pharmaceuticals Q3 EPS $(0.04) May Not Compare To $(0.87) Estimate, Sales $90.971M Beat $85.91M Estimate

GW Pharmaceuticals (NASDAQ: GWPH) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.87) by 95.4 percent.

Benzinga · 11/05/2019 21:51

GW Pharmaceuticals (NASDAQ: GWPH) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.87) by 95.4 percent. This is a 82.61 percent increase over losses of $(0.23) per share fromGW Pharmaceuticals (NASDAQ:GWPH) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.87) by 95.4 percent. This is a 82.61 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $90.971 million which beat the analyst consensus estimate of $85.91 million by 5.89 percent. This is a 3.66K percent increase over sales of $2.42 million the same period last year.